Literature DB >> 11520156

Carcinosarcoma of the uterus: immunohistochemical and genetic analysis of clonality of one case.

M Watanabe1, K Shimizu, H Kato, H Imai, H Nakano, M Sugawa, T Shiraishi.   

Abstract

BACKGROUND: Carcinosarcomas of the uterus are characterized by admixtures of malignant epithelial and stromal cells, and their histogenesis remains controversial. CASE: An operated case of carcinosarcoma of the uterus in a 49-year-old woman is reported with clonal analysis. The tumor was composed of carcinomatous, sarcomatous, and transitional elements in the frontal wall of the uterine body and therefore was diagnosed as a carcinosarcoma. On immunohistochemical analysis, the sarcomatous component proved negative for epithelial membrane antigen and keratin while both components were positive for vimentin. Analysis of X-chromosome inactivation showed the same pattern throughout and additionally, the same K-ras and p53 mutations were homogeneously detected. Microsatellite instability analysis showed loss of heterozygosity at D5S346 in the sarcomatous but not the carcinomatous component.
CONCLUSIONS: This tumor appears monoclonal in line with the combination tumor theory, with late divergence in genetic alteration in the sarcomatous elements. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11520156     DOI: 10.1006/gyno.2001.6307

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  8 in total

1.  Spindle cell carcinoma of head and neck: an immunohistochemical and molecular approach to its pathogenesis.

Authors:  Ruchika Gupta; Sompal Singh; Suresh Hedau; Sonu Nigam; Bhudev C Das; Ishwar Singh; Ashish Kumar Mandal
Journal:  J Clin Pathol       Date:  2006-05-26       Impact factor: 3.411

2.  Serum CA125 predicts extrauterine disease and survival in uterine carcinosarcoma.

Authors:  Gloria S Huang; Lydia G Chiu; Juliana S Gebb; Marc J Gunter; Paniti Sukumvanich; Gary L Goldberg; Mark H Einstein
Journal:  Gynecol Oncol       Date:  2007-10-23       Impact factor: 5.482

Review 3.  Coexistence of homologous-type cervical carcinosarcoma with endometrioid-type G1 endometrial cancer: a case report with an immunohistochemical study.

Authors:  Andrzej Semczuk; Eva Colas; Beata Walczyna; Maciej Joźwik; Andrzej Pyra; Anna Semczuk-Sikora; Tomasz Rechberger
Journal:  Int J Clin Exp Pathol       Date:  2014-09-15

4.  Primary malignant mixed müllerian tumor of the peritoneum a case report with review of the literature.

Authors:  Fisnik Kurshumliu; Helle Rung-Hansen; Vibeke Ravn Skovlund; Lumturije Gashi-Luci; Thomas Horn
Journal:  World J Surg Oncol       Date:  2011-02-04       Impact factor: 2.754

5.  Tissue microarray analysis of hormonal signaling pathways in uterine carcinosarcoma.

Authors:  Gloria S Huang; Rebecca C Arend; Maomi Li; Marc J Gunter; Lydia G Chiu; Susan Band Horwitz; Gary L Goldberg
Journal:  Am J Obstet Gynecol       Date:  2009-02-06       Impact factor: 8.661

6.  Molecular genetic findings in two cases of sarcomatoid carcinoma of the ureter: evidence for evolution from a common pluripotent progenitor cell?

Authors:  Hans-Ullrich Völker; Andreas Zettl; Georg Schön; Vitus Heller; Elmar Heinrich; Andreas Rosenwald; Mathias Handwerker; Hans-Konrad Müller-Hermelink; Alexander Marx; Philipp Ströbel
Journal:  Virchows Arch       Date:  2008-02-12       Impact factor: 4.064

7.  Inter-component immunohistochemical assessment of proliferative markers in uterine carcinosarcoma.

Authors:  Andrzej Pyra; Aneta Adamiak-Godlewska; Dorota Lewkowicz; Beata Bałon; Marek Cybulski; Anna Semczuk-Sikora; Andrzej Semczuk
Journal:  Oncol Lett       Date:  2022-08-31       Impact factor: 3.111

8.  In-depth molecular profiling of the biphasic components of uterine carcinosarcomas.

Authors:  Melissa K McConechy; Lien N Hoang; Michael Herman Chui; Janine Senz; Winnie Yang; Nirit Rozenberg; Robertson Mackenzie; Jessica N McAlpine; David G Huntsman; Blaise A Clarke; Cyril Blake Gilks; Cheng-Han Lee
Journal:  J Pathol Clin Res       Date:  2015-04-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.